BeStock  
Stocks › Medical Devices › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3306Medical Devices
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–

CTKB Stock News

Headlines matching Cytek Biosciences or the CTKB ticker, most recent first.

  • Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $7.5Market news · 6 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $5 NegativeMarket news · 6 Aug 2026 · Direct mention
  • TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $5Market news · 6 Aug 2026 · Direct mention
  • Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $4.75 PositiveMarket news · 13 May 2026 · Direct mention
  • Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $4.12 NegativeMarket news · 12 May 2026 · Direct mention
  • TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Raises Target Price to $5 PositiveMarket news · 27 Feb 2026 · Direct mention
  • Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $7.5Market news · 5 Nov 2026 · Direct mention
  • Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $7 PositiveMarket news · 10 Nov 2026 · Direct mention
  • Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $6 PositiveMarket news · 23 Oct 2026 · Direct mention
  • Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8Market news · 11 Aug 2025 · Direct mention
  • Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $7 NegativeMarket news · 29 May 2025 · Direct mention
  • Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $4 NegativeMarket news · 17 May 2025 · Direct mention
  • TD Cowen Downgrades Cytek Biosciences(CTKB.US) to Hold Rating, Cuts Target Price to $4 NegativeMarket news · 10 May 2025 · Direct mention
  • Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8 NegativeMarket news · 4 Mar 2025 · Direct mention
  • Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $9Market news · 14 Mar 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on CTKB.

Sign in to join the discussion.

Scroll to Top